Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Diagnosis and treatment of tuberculosis, and Infectious Diseases and Tuberculosis.
LysG-driven transcriptional network rewiring underlies lineage-specific phenotypes in Mycobacterium tuberculosis.
Large-scale testing of antimicrobial lethality at single-cell resolution predicts mycobacterial infection outcomes.
Within-host evolution of drug tolerance in <i>Mycobacterium tuberculosis</i>.
Human genetic ancestry, <i>Mycobacterium tuberculosis</i> diversity, and tuberculosis disease severity in Dar es Salaam, Tanzania.
Proteogenomic discovery of novel small proteins in clinical
<i>Mycobacterium tuberculosis</i>
strains
Human genetic ancestry, Mycobacterium tuberculosis diversity, and tuberculosis disease severity in Dar es Salaam, Tanzania
Ecology, global diversity and evolutionary mechanisms in the Mycobacterium tuberculosis complex.
Transmission as a Key Driver of Resistance to the New Tuberculosis Drugs.
Gene conversion and duplication contribute to genetic variation in an outbreak of <i>Mycobacterium tuberculosis</i>.
Onset of infectiousness explains differences in transmissibility across Mycobacterium tuberculosis lineages.
Drug-induced differential culturability in diverse strains of Mycobacterium tuberculosis.
Variability in intrinsic drug tolerance in <i>Mycobacterium tuberculosis</i> corresponds with phylogenetic lineage.
Clinical and bacterial determinants of unfavorable tuberculosis treatment outcomes: an observational study in Georgia.
Granulysin Antimicrobial Activity Promotes Dormancy in Mycobacterium tuberculosis.
Mycobacteria beyond disease.
Clinical and bacterial determinants of unfavorable tuberculosis treatment outcomes: an observational study in Georgia
Mycobacterium tuberculosis complex Lineage 1: A neglected cause of tuberculosis.
Genome-to-genome analysis reveals associations between human and mycobacterial genetic variation in tuberculosis patients from Tanzania.
Linking genetic and phenotypic bedaquiline resistance in Mycobacterium tuberculosis strains from Georgia.
Epistasis between drug resistance-conferring mutations in
<i>Mycobacterium tuberculosis</i>
HIV co-infection is associated with reduced Mycobacterium tuberculosis transmissibility in sub-Saharan Africa.
Bacterial diversity dominates variable macrophage responses of tuberculosis patients in Tanzania.
A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis
A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis.
A Genome-Focused Investigation Reveals the Emergence of a <i>Mycobacterium tuberculosis</i> Strain Related to Multidrug-Resistant Tuberculosis in the Amazon Region of Brazil.
Genetic Characterization and Population Structure of Drug-Resistant <i>Mycobacterium tuberculosis</i> Isolated from Brazilian Patients Using Whole-Genome Sequencing.
Diagnostic accuracy of a sequence-specific <i>Mtb</i>-DNA hybridization assay in urine: a case-control study including subclinical TB cases.
Onset of infectiousness explains differences in transmissibility across
<i>Mycobacterium tuberculosis</i>
lineages
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement